title: Smoking cessation with four nicotine replacement regimes in a lung clinic.
abstract: Smoking cessation is a key intervention for prevention of several lung diseases. The aim of the present study was to compare the effect of smoking cessation with nicotine replacement in a lung clinic in a low resource set-up suitable for implementation in other lung clinics. This was an open, randomized trial with 4 different nicotine replacement regimes combined with minimal behavioural support in daily routine. A total of 446 smokers (>9 cigarettes x day(-1)) were allocated to a nurse-conducted smoking cessation programme with 4 treatment arms: a 5-mg nicotine patch ("placebo"), a 15-mg nicotine patch, nicotine inhaler, and a 15-mg nicotine patch plus nicotine inhaler. Recommended use of the nicotine products were 3 months with the possibility of continuing use up to 9 months on an individual basis. Individual follow-up studies were scheduled after 2 and 6 weeks, 3, 6, 9 and 12 months. The 12-month point prevalence was 6% (5-mg patch (placebo)), 16% (15-mg patch) (p<0.05), 9% (inhaler) and 11% (15-mg patch plus inhaler), respectively. To conclude, the set-up investigated in this study which included minimal behavioural support with nicotine patches should be evaluated in other lung clinics, as it doubled success rate when compared to a placebo with a 1-yr point prevalence of 16% and also the resources used are limited.
authors: Dept of Pulmonary Medicine, Gentofte University Hospital, Hellerup, Denmark.
authors: P
authors: P
authors: Tønnesen
authors: K L
authors: KL
authors: Mikkelsen
mesh_terms: D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D002248:Carbon Monoxide / Q000032:analysis; D000697:Central Nervous System Stimulants / Q000008:administration & dosage*; D003367:Cotinine / Q000032:analysis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009538:Nicotine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D011109:Polymethacrylic Acids / Q000008:administration & dosage*; D011145:Polyvinyls / Q000008:administration & dosage*; D016016:Proportional Hazards Models; D016540:Smoking Cessation / Q000379:methods*; D013147:Spirometry; D018709:Statistics, Nonparametric; D011795:Surveys and Questionnaires; D061485:Tobacco Use Cessation Devices; D016896:Treatment Outcome
chemical_list: D000697:Central Nervous System Stimulants; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D009538:Nicotine; D002248:Carbon Monoxide; D003367:Cotinine